Upcoming Courses

Responding to Risk for Psychosis Among College Students: Tools for Early Engagement, Assessment, and Treatment

Matcheri Keshavan, MD, Michelle L. West, PhD, Kristen Woodberry, MSW, PhD, Michelle Friedman-Yakoobian, PhD

November 27, 2017 | Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston MA 02215 | Sherman Auditorium

This program aims help mental health and health professionals working with college-aged aged students expand their knowledge about early signs of psychosis and recommended assessment and intervention strategies. The ultimate goal is to create opportunities in which young people experiencing the early signs of major mental illness can safely share what they are experiencing and be guided to appropriate help. Through a mix of teaching, first-hand accounts, discussion, and skills practice, participants will gain comfort asking about signs of risk, speaking to youth and families about risk, implementing intervention strategies to tar-get early psychosis symptoms, and referring to local specialized services. The program will highlight strategies and guidelines for effectively managing tricky conversations, cultural factors, denial, and safety concerns.

Here’s the link to the conference slides on the website

(the conference page): http://cedarclinic.org/index.php/education-and-outreach/conferences.

 

This course is designed so that participants will be able to:

1) Explain the rationale for early detection and intervention before onset of psychotic disorders, and learn innovative strategies for engaging young people at risk.
2) Identify and describe at least five early symptoms that may indicate possible risk for psychosis.
3) Learn language and questions that can help to gather information about psychosis spec-trum symptoms, and to communicate risk to young people and families
4) Increase comfort assessing for risk of harm in the context of psychosis risk symptoms.
5) Describe and experience more comfort implementing recommended psychotherapeu-tic strategies for psychosis spectrum symptoms.

Additional Information

Registration and Introduction
8:15-9 Registration
9-9:10 Opening Remarks
Matcheri Keshavan, MD
Assessment and Engagement
9:10-9:50 Early Intervention Turns the Tide
Vinod Srihari, MD
9:50-10:30 Screening, Assessment Tools, and Diagnostic Considerations for
Psychosis Spectrum Symptoms
Megan Graham, LMHC, Janine Rodenheiser-Hill, PhD
Break
10:45-11:05 Addressing Risk for Violence and Suicide
Michelle West, PhD
11:05-11:55 Innovative Models and Tools for Engaging Youth at Risk
Moderator: Kristen Woodberry, PhD
Panelists: Candice Porter, Marsha Ellison
11:55-12:20 99 Faces Introduction and Video
Lynda Cuttrell
12:20-1 Lunch
Psychosocial Interventions for Youth with Early Psychosis
Spectrum Symptoms
1-1:15 Session Introduction: Early Psychosis, Brain Plasticity, and the
Importance of Psychosocial Treatment
Matcheri Keshavan, MD
1:15-1:30 Expansion of Early Psychosis Efforts in MA
Margaret Guyer, PhD
1:30-1:50 Talking with Youth and Families about Psychosis Risk
Kristen Woodberry, PhD; Jeanne Haley, MSW, LICSW
Break
2-2:20 Panel: Local Treatment Innovations
Kristen Woodberry, PhD, Michelle Friedman-Yakoobian, PhD, Raquelle Mesholam-
Gately, PhD
2:20-2:50 The Right Help at the Right Time
Dan
2:50-3:20 Interventions for Youth at Risk for Psychosis
Michelle Friedman-Yakoobian, PhD
Conclusion
3:50-4 Closing Remarks Matcheri Keshavan, MD

Beth Israel Deaconess Department of Psychiatry Foundation, Inc./Contact Hours: 6.5

Accreditation:

Psychologists: The Continuing Education Program at Beth Israel Deaconess Medical School, a major teaching hospital of Harvard Medical School, is approved by the American Psychological Association to offer continuing education for psychologists. The Continuing Education Program at Beth Israel Deaconess Medical School, a major teaching hospital of Harvard Medical School, maintains responsibility for this program.
Counselors: The Continuing Education Program at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School, has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 5689. Programs that do not qualify for NBCC credit are clearly identified. The Continuing Education Program at Beth Israel Deaconess Medical Cen-ter, a major teaching hospital of Harvard Medical School, is solely responsible for all aspects of the programs.
Nurses: The Continuing Education Program at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School, meets the specifications of the Board of Registration in Nursing in Massachusetts (244 CMR).
Social Workers: For information on the status of the application to the Massachusetts Chapter of the National Association of Social Workers, please email jflynn2@bidmc.harvard.edu.
Physicians: There are no Category I credits available to physicians for this conference. This conference qualifies for Category II credits.

Registration Fee

$20

Faculty/Speaker Bios

Marsha Ellison, PhD., Associate Professor, Department of Psychiatry; Deputy Director, Transitions Research and Training Center
Michelle Friedman-Yakoobian, PhD, Clinical Director of the Center for Early Detec-tion, Assessment and Response to Risk (CEDAR) Clinic at MMHC; Instructor in Psychiatry, Harvard Medical School
Megan Graham, LMHC, MS, Referral Coordinator; Psychological Studies Interviewer; CRC & CEDAR Clinic
Margaret Guyer, PhD, Director, DMH First Episode Psychosis Initiative; Clinician, De-partment of Mental Health (DMH)
Jeanne M. Haley, MSW, LICSW, Clinician at Framingham State University, Counseling Center
Matcheri S. Keshavan, MD, Director, Commonwealth Research Center (CRC); Stanley Cobb Professor of Psychiatry, Harvard Medical School (HMS); Vice-Chair, Division of Public Psychiatry, HMS
Raquelle I. Mesholam-Gately, PhD, Instructor in Psychiatry, Harvard Medical School
Candice Porter, [title]
Janine Rodenhiser-Hill, Ph.D., Instructor of Psychology, Department of Psychiatry, at Harvard Medical School (HMS) and Beth Israel Deaconess Medical Center (BIDMC)
Vinod Srihari, MD, Associate Professor of Psychiatry; Associate Program Director, Psychi-atry Residency Training; Director, STEP Program; Yale Global Mental Health Program
Michelle L. West, PhD, Supervising psychologist, CEDAR Clinic; Project Director of the North American Prodrome Longitudinal Study (NAPLS); Instructor in Psychology of Harvard Medical School (HMS); Commonwealth Research Center (CRC) at BIDMC
Kristen Woodberry, PhD, MSW, Assistant Professor of Psychology, Harvard Medical School (HMS); Director of Psychosocial Protective Mechanisms, Commonwealth Research Center (CRC)

Sponsored by

Center for Early Detection, Assessment, and Response to Risk (CEDAR) Clinic
Continuing Education Program at Beth Israel Deaconess Medical Center (BIDMC), a major teaching hospital of Harvard Medical School (HMS)
Commonwealth Research Center (CRC) of the Department of Mental Health (DMH)
Supported in part by an unrestricted educational grant from the Sidney R. Baer, Jr. Foundation